Loomis Sayles & CO L P Syneos Health, Inc. Transaction History

Loomis Sayles & CO L P

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$34.5 - $42.19 $7,866 - $9,619	-228 Reduced 71.03%	93 $4,000
Q1 2023 May 11, 2023	BUY	$33.32 - $40.98 $8,896 - $10,941	267 Added 494.44%	321 $11,000
Q4 2022 Feb 10, 2023	BUY	$25.32 - $51.45 $784 - $1,594	31 Added 134.78%	54 $2,000
Q3 2022 Nov 14, 2022	SELL	$46.5 - $79.14 $18.6 Million - $31.6 Million	-399,882 Reduced 99.99%	23 $1,000
Q2 2022 Aug 05, 2022	SELL	$63.06 - $84.75 $188,801 - $253,741	-2,994 Reduced 0.74%	399,905 $28.7 Million
Q1 2022 May 13, 2022	SELL	$74.15 - $99.36 $4.15 Million - $5.57 Million	-56,032 Reduced 12.21%	402,899 $32.6 Million
Q4 2021 Feb 14, 2022	SELL	$86.01 - $102.89 $410,439 - $490,991	-4,772 Reduced 1.03%	458,931 $47.1 Million
Q3 2021 Nov 12, 2021	BUY	$84.7 - $96.31 $4.64 Million - $5.27 Million	54,728 Added 13.38%	463,703 $40.6 Million
Q2 2021 Aug 13, 2021	BUY	$76.44 - $89.57 $1.23 Million - $1.45 Million	16,144 Added 4.11%	408,975 $36.6 Million
Q1 2021 May 17, 2021	BUY	$67.36 - $80.76 $14,280 - $17,121	212 Added 0.05%	392,831 $29.8 Million
Q4 2020 Feb 12, 2021	BUY	$53.08 - $69.86 $9.55 Million - $12.6 Million	179,874 Added 84.55%	392,619 $26.7 Million
Q3 2020 Nov 12, 2020	BUY	$51.29 - $65.09 $10.9 Million - $13.8 Million	212,745 New	212,745 $11.3 Million
Q2 2019 Aug 14, 2019	SELL	$40.81 - $52.42 $20,405 - $26,210	-500 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$36.91 - $55.7 $10,630 - $16,041	288 Added 135.85%	500 $26,000
Q4 2018 Feb 14, 2019	BUY	$36.49 - $51.72 $7,735 - $10,964	212 New	212 $8,000

731K

Ticker SYNH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,653,000
Description
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.